An Italian startup, specialized in bioprinting activity, develops 3D-bioprinters targeting human tissue repair and regeneration with dermatology, orthopedic, dental and osteo-articular applications. The startup know-how is a combination of pharmaceutical technology, mechanical engineering, biomaterials, biotechnology and analytical chemistry.
The startup is proposing an innovative 3D printed tissue repair therapies, suitable to help the healing of chronic wounds, through bio-absorbable hydrogels based on chitosan dressing.
The R&D area of the startup is working on the development of new materials (bio-inks), like stimuli-sensitive bio compatible and bioresorbable polymers. These bio-inks are dispensed from the 3D printer in a layer-by-layer approach to build finely tuned scaffolds (materials engineered to cause cellular interactions to form new functional tissues) in a variety of advanced designs, presenting high improved cell-compatibility.
Experimental models (in vivo experiments), performed and coordinated by the startup’s experienced staff, are used for investigating the tissue repair and tissue regeneration properties of the developed products.
The startup is looking for industrial partners working in the health-care area (pharmaceutical or biomedical companies) interested in the development of innovative medical devices in the regenerative medicine field.
The startup wants to pursue the industrialization process of its products, throughout a manufacturing agreement, but it is also open to financial or license agreement to support the product industrialization.